Toxicogenomics: The challenges and opportunities to identify biomarkers, signatures and thresholds to support mode-of-action

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 746, Issue 2, 2012, Pages 97-103

  Currie, Richard A ^a  

^a JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Biomarkers; Liver carcinogenesis; Mode of action; Toxicogenomics

Indexed keywords

DNA; MICRORNA 200;

ARTICLE; CANCER RISK; DISEASE MARKER; DNA FINGERPRINTING; DNA SYNTHESIS; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TOXICOLOGY; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; QUALITY CONTROL; REGULATORY MECHANISM; RISK ASSESSMENT; TOXICITY; TUMOR GROWTH;

BIOLOGICAL MARKERS; HAZARDOUS SUBSTANCES; RISK ASSESSMENT; TOXICOGENETICS;

EID: 84861570461     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2012.03.002     Document Type: Article

References (42)

1. Thomas R.S., Rank D.R., Penn S.G., Zastrow G.M., Hayes K.R., Pande K., Glover E., Silander T., Craven M.W., Reddy J.K., Jovanovich S.B., Bradfield C.A. Identification of toxicologically predictive gene sets using cDNA microarrays. Mol. Pharmacol. 2001, 60:1189-1194.
2. Thomas R.S., Pluta L., Yang L., Halsey T.A. Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays. Toxicol. Sci. 2007, 97:55-64.
3. Ellinger-Ziegelbauer H., Stuart B., Wahle B., Bomann W., Ahr H. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat. Res. 2005, 575:61-84.
4. Ellinger-Ziegelbauer H., Gmuender h., Bandenburg A., Ahr H.J. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. Mutat. Res. 2008, 637:23-39.
5. Fielden M.R., Eynon B.P., Natsoulis G., Jarnagin K., Banas D., Kolaja K.L. A gene expression signature that predicts the future onset of drug-induced renal tubular toxicity. Toxicol. Pathol. 2005, 33:675-683.
6. Fielden M.R., Brennan R., Gollub J. A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. Toxicol. Sci. 2007, 99:90-100.
7. Nie A.Y., McMillian M., Parker J.B., Leone A., Bryant S., Yieh L., Bittner A., Nelson J., Carmen A., Wan J., Lord P.G. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity. Mol. Carcinog. 2006, 45:914-933.
8. Pennie W., Pettit S.D., Lord P.G. Toxicogenomics in risk assessment: an overview of an HESI collaborative research program. Environ. Health Perspect. 2004, 112:417-419.
9. Consortium M.A.Q.C., Shi L., Reid L.H., Jones W.D., Shippy R., Warrington J.A., Baker S.C., Collins P.J., de Longueville F., KawasakI.E.S., Lee K.Y., Luo Y., Sun Y.A., Willey J.C., Setterquist R.A., Fischer G.M., Tong W., Dragan Y.P., Dix D.J., Frueh F.W., Goodsaid F.M., Herman D., Jensen R.V., Johnson C.D., Lobenhofer E.K., Puri R.K., Schrf U., Thierry-Mieg J., Wang C., Wilson M., Wolber P.K., Zhang L., Amur S., Bao W., Barbacioru C.C., Lucas A.B., Bertholet V., Boysen C., Bromley B., Brown D., Brunner A., Canales R., Cao X.M., Cebula T.A., Chen J.J., Cheng J., Chu T.M., Chudin E., Corson J., Corton J.C., Croner L.J., Davies C., Davison T.S., Delenstarr G., Deng X., Dorris D., Eklund A.C., Fan X.H., Fang H., Fulmer-Smentek S., Fuscoe J.C., Gallagher K., Ge W., Guo L., Guo X., Hager J., Haje P.K., Han J., Han T., Harbottle H.C., Harris S.C., Hatchwell E., Hauser C.A., Hester S., Hong H., Hurban P., Jackson S.A., Ji H., Knight C.R., Kuo W.P., LeClerc J.E., Levy S., Li Q.Z., Liu C., Liu Y., Lombardi M.J., Ma Y., Magnuson S.R., Maqsodi B., McDaniel T., Mei M., Myklebost O., Ning B., Novoradovskaya N., Orr M.S., Osborn T.W., Papallo A., Patterson T.A., Perkins R.G., Peters E.H., Peterson R., Philips K.L., Pine P.S., Pusztai L., Qian F., Ren H., Rosen M., Rosenzweig B.A., Samaha R.R., Schena M., Schroth G.P., Shchegrova S., Smith D.D., Staedtler F., Su Z., Sun H., Szallasi Z., Tezak Z., Thierry-Mieg D., Thompson K.L., Tikhonova I., Turpaz Y., Vallanat B., Van C., Walker S.J., Wang S.J., Wang Y., Wolfinger R., Wong A., Wu J., Xiao C., Xie Q., Xu J., Yang W., Zhang L., Zhong S., Zong Y., Slikker W. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 2006, 24:1151-1161.
10. Chen J.J., Hsueh H.M., Delongchamp R.R., Lin C.J., Tsai C.A. Reproducibility of microarray data: a further analysis of microarray quality control (MAQC) data. BMC Bioinformatics 2007, 8:412.
11. Fielden M.R., Nie A., McMillian M., Elangbam C.S., Trela B.A., Yang Y., Dunn R.T., Dragan Y., Fransson-Stehen R., Bogdanffy M., Adams S.P., Foster W.R., Chen S.J., Rossi P., Kasper P., Jacobson-Kram D., Tatsuoka K.S., Wier P.J., Gollub J., Halbert D.N., Roter A., Young J.K., Sina J.F., Marlowe J., Martus H.J., Aubrecht J., Olaharski A.J., Roome N., Nioi P., Pardo I., Snyder R., Perry R., Lord P., Mattes W., Car B.D. Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat. Toxicol. Sci. 2008, 103:28-34. Predictive Safety Testing Consortium; Carcinogenicity Working Group.
12. Ebbels T.M., Keun H.C., Beckonert O.P., Bollard M.E., Lindon J.C., Holmes E., Nicholson J.K. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. J. Proteome Res. 2007, 6:4407-4422.
13. Wetmore B.A., Brees D.J., Singh R., Watkins P.B., Andersen M.E., Loy J., Thomas R.S. Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury. Hepatology 2010, 51:2127-2139.
14. Ward W.O., Delker D.A., Hester S.D., Thai S.F., Wolf D.C., Allen J.W., Nesnow S. Transcriptional profiles in liver from mice treated with hepatotumorigenic and nonhepatotumorigenic triazole conazole fungicides: propiconazole, triadimefon, and myclobutanil. Toxicol. Pathol. 2006, 34:863-878.
15. Shi L., Campbell G., Jones W.D., Campagne F., Wen Z., Walker S.J., Su Z., Chu T.M., Goodsaid F.H., Pusztai L., Shaughnessy J.D., Oberthuer A., Thomas R.S., Paules R.S., Fielden M., Barlogie B., Chen W., Du P., Fischer M., Furlanello C., Gallas B.D., Ge X., Megherbi D.B., Symmans W.F., Wang M.D., Zhang J., Bitter H., Brors B., Bushel P.R., Bylesjo M., Chen M., Cheng J., Cheng J., Chou J., Davison T.S., Delorenzi M., Deng Y., Devanarayan V., Dix D.J., Dopazo J., Dorff K.C., Elloumi F., Fan J., Fan S., Fan X., Fang H H., Gonzaludo N., Hess K.R., Hong H., Huan J., Irizarry R.A., Judson R., Juraeva D., Lababidi S., Lambert C.G., Li L., Li Y., Li Z., Lin S.M., Liu G., Lobenhofer E.K., Luo J., Luo W., McCall M.N., Nikolsky Y., Pennello G.A., Perkins R.G., Philip R., Popovici V., Price N.D., Qian F., Scherer A., Shi T., Shi W., Sung J., Thierry-Mieg D., Thierry-Mieg J., Thodima V., Trygg J., Vishnuvajjala L., Wang S.J., Wu J., Wu Y., Xie Q., Yousef W.A., Zhang L., Zhang X., Zhong S., Zhou Y., Zhu A., Arasappan D., Bao W., Lucas A.B., Berthold F., Brennan R.J., Buness A., Catalano J.G., Chang C., Chen R., Cheng Y., Cui J., Czika W., Demichelis F., Deng X., Dosymbekov D., Eils R., Feng Y., Fostel J., Fulmer-Smentek S., Fuscoe J.C., Gatto L., Ge W., Goldstein D.R., Guo L., Halbert D.N., Han J., Harris S.C., Hatzis C., Herman D., Huang J., Jensen R.V., Jiang R., Johnson C.D., Jurman G., Kahlert Y., Khuder S.A., Kohl M., Li J., Li L., Li M., Li Q.Z., Li S., Li Z., Liu J., Liu Y., Liu Z., Meng L., Madera M., Martinez-Murillo F., Medina I., Meehan J., Miclaus K., Moffitt R.A., Montaner D., Mukherjee P., Mulligan G.J., Neville P., Nikolskaya T., Ning B., Page G.P., Parker J., Parry R.M., Peng X., Peterson R.L., Phan J.H., Quanz B., Ren Y., Riccadonna S., Roter A.H., Samuelson F.W., Schumacher M.M., Shambaugh J.D., Shi Q., Shippy R., Si S., Smalter A., Sotiriou C., Soukup M., Staedtler F., Steiner G., Stokes T.H., Sun Q., Tan P.Y., Tang R., Tezak Z., Thorn B., Tsyganova M., Turpaz Y., Vega S.C., Visintainer R., von Frese J., Wang C., Wang E., Wang J., Wang W., Westermann F., Willey J.C., Woods M., Wu S., Xiao N., Xu J., Xu L., Yang l., Zeng X., Zhang J., Zhang L., Zhang M., Zhao C., Puri R.K., Scherf U., Tong W., Wolfinger R.D. MAQC, Consortium, The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat. Biotechnol. 2010, 28:827-838.
16. Sonich-Mullin C., Fielder R., Wiltse J., Baetcke K., Dempsey J., Fenner-Crisp P., Grant D., Hartley M., Knaap A., Kroese D., Mangelsdorf I., Meek E., Rice J.M., Younes M. International programme on chemical safety IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 2001, 34:146-152.
17. Meek M.E., Bucher J.R., Cohen S.M., Dellarco V., Hill R.N., Lehman-McKeeman L.D., Longfellow D.G., Pastoor T., Seed J., Patton D.E. A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol. 2003, 33:591-653.
18. Boobis A.R., Cohen S.M., Dellarco V., McGregor D., Meek M.E., Vickers C., Willcocks D., Farland W. IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 2006, 36:781-792.
19. Hill A.B. The environment and disease: association or causation?. Proc. R. Soc. Med. 1965, 58:295-300.
20. Julien E., Boobis A.R., Olin S.S. ILSI Research Foundation Threshold Working Group, the key events dose-response framework: a cross-disciplinary mode-of-action based approach to examining dose-response and thresholds. Crit. Rev. Food Sci. Nutr. 2009, 49:682-689.
21. Boobis A.R., Daston G.P., Preston R.J., Olin S.S. Application of key events analysis to chemical carcinogens and noncarcinogens. Crit. Rev. Food Sci. Nutr. 2009, 49:690-707.
22. Waterman C.L., Currie R.A., Cottrell L.A., Dow J., Wright J., Waterfield C.J., Griffin J.L. An integrated functional genomic study of acute phenobarbital exposure in the rat. BMC Genomics 2010, 11:9.
23. Thomas R.S., Allen B.C., Nong A., Yang L., Bermudez E., Clewell H.J., Andersen M.E. A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. Toxicol. Sci. 2007, 98:240-248.
24. Bercu J.P., Jolly R.A., Flagella K.M., Baker T.K., Romero P., Stevens J.L. Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens. Regul. Toxicol. Pharmacol. 2010, 58:369-381.
25. Thomas R.S., Clewell H.J., Allen B.C., Wesselkamper S.C., Wang N.C., Lambert J.C., Hess-Wilson J.K., Zhao Q.J., Andersen M.E. Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment. Toxicol. Sci. 2011, 120:194-205.
26. Fell D. Understanding the Control of Metabolism 2006, Portland Press, London.
27. Sturm O.E., Orton R., Grindlay J., Birtwistle M., Vyshemirsky V., Gilbert D., Calder M., Pitt A., Kholodenko B., Kolch W. The mammalian MAPK/ERK pathway exhibits properties of a negative feedback amplifier. Sci. Signal. 2010, 3:ra90.
28. Kiel C., Serrano L. Cell type-specific importance of ras-c-raf complex association rate constants for MAPK signalling. Sci. Signal. 2009, 2:ra38.
29. Kholodenko B.N., Hoek J.B., Westerhoff H.V., Brown G.C. Quantification of information transfer via cellular signal transduction pathways. FEBS Lett. 1997, 414:430-434.
30. Kholodenko B.N., Kiyatkin A., Bruggeman F.J., Sontag E., Westerhoff H.V., Hoek J.B. Untangling the wires: a strategy to trace functional interactions in signaling and gene networks. Proc. Natl. Acad. Sci. U. S. A. 2009, 99:12841-12846.
31. Milo R., Shen-Orr S., Itzkovitz S., Kashtan N., Chklovskii D., Alon U. Network motifs: simple building blocks of complex networks. Science 2002, 298:824-827.
32. Ma'ayan A., Jenkins S.L., Neves S., Hasseldine A., Grace E., Dubin-Thaler B., Eungdamrong N.J., Weng G., Ram P.T., Rice J.J., Kershenbaum A., Stolovitzky G.A., Blitzer R.D., Iyengar R. Formation of regulatory patterns during signal propagation in a Mammalian cellular network. Science 2005, 309:1078-1083.
33. Ma'ayan A., Iyengar R. From components to regulatory motifs in signalling networks. Brief Funct. Genomic Proteomic 2006, 5:57-61.
34. Columbano A., Ledda-Columbano G.M., Pibiri M., Cossu C., Menegazzi M., Moore D.D., Huang W., Tian J., Locker J. Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. Hepatology 2005, 42:1118-1126.
35. Yi Y.W., Kim D., Jung N., Hong S.S., Lee H.S., Bae I. Gadd45 family proteins are coactivators of nuclear hormone receptors. Biochem. Biophys. Res. Commun. 2000, 272:193-198.
36. Yamamoto Y., Negishi M. The antiapoptotic factor growth arrest and DNA-damage-inducible 45 beta regulates the nuclear receptor constitutive active/androstane receptor-mediated transcription. Drug Metab. Dispos. 2008, 36:1189-1193.
37. Yamamoto Y., Moore R., Flavell R.A., Lu B., Negishi M. Nuclear receptor CAR represses TNFalpha-induced cell death by interacting with the anti-apoptotic GADD45B. PLoS One 2010, 5:e10121.
38. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10:593-601.
39. Bracken C.P., Gregory P.A., Kolesnikoff N., Bert A.G., Wang J., Shannon M.F., Goodall G.J. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008, 68:7846-7854.
40. Iida M., Anna C.H., Hartis J., Bruno M., Wetmore B., Dubin J.R., Sieber S., Bennett L., Cunningham M.L., Paules R.S., Tomer K.B., Houle C.D., Merrick A.B., Sills R.C., Devereux T.R. Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. Carcinogenesis 2003, 24:757-770.
41. Currie R.A., Bombail V., Oliver J.D., Moore D.J., Lim F.L., Gwilliam V., Kimber I., Chipman K., Moggs J.G., Orphanides G. Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate. Toxicol. Sci. 2005, 86:453-469.
42. Phillips J.M., Burgoon L.D., Goodman J.I. The constitutive active/androstane receptor facilitates unique phenobarbital-induced expression changes of genes involved in key pathways in precancerous liver and liver tumors. Toxicol. Sci. 2009, 110:319-333.